Helomics Corp-医療機器分野:企業M&A・提携分析

◆英語タイトル:Helomics Corp - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011160
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Helomics Corp(Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company’s products include chemofx, biospecifx, genefx colon and genefx lung. Its chemofx is a drug response marker, which is used to test tumor response to various chemotherapeutic and biologic agents. Helomics’ biospecifx is a biomarker that is used to test drug response and patient prognosis. The company also offers contract research, genefx colon, which is a microarray-based gene signature that identifies patients at risk of recurrence. It serves clinical testing, precision medicine and cancer research needs of physicians. The company has operations in US and Canada. Precision is headquartered in Pittsburgh, Pennsylvania, the US.

Helomics Corp – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Helomics Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Helomics Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Helomics Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Helomics Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Helomics Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Helomics Corp, Medical Equipment, Deal Details 10
Venture Financing 10
Precision Therapeutics Raises US$14 Million In Venture Financing 10
Private Equity 11
Healthcare Royalty Invests USD60 Million in Precision Therapeutics 11
Partnerships 12
Med BioGene Enters Into Licensing Agreement With Precision Therapeutics 12
Skyline Medical Forms Joint Venture with Helomics 14
Skyline Medical and Helomics Enter into Partnership 15
Helomics Partners with MDNA Life Sciences 16
Acquisition 17
Skyline Medical to Acquire 25% Stake in Helomics 17
Helomics Corp – Key Competitors 18
Helomics Corp – Key Employees 19
Helomics Corp – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Strategy And Business Planning 21
Jun 01, 2017: Helomics and the Pittsburgh Life Sciences Greenhouse Partner to Establish a Biotechnology Incubator Dedicated to Diagnostics and Precision Medicine 21
Apr 19, 2016: Helomics Announces Second Phase of Realignment Towards a Research and Clinical Products Company in Personalized Healthcare 22
Product News 23
Jun 03, 2016: Helomics to Attend the 2016 BIO International Convention 23
03/15/2016: Helomics Launches GeneFx Colon to Identify Patients with High Risk Stage II Colon Cancer 24
02/08/2016: Helomics Launches CellFx, a Key Research Component of Their Precision Cellular Analytical Platform Further Expanding Their Comprehensive Tumor Profiling Offering to Patients, Physicians and Life Science Industry 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Helomics Corp, Medical Equipment, Key Facts 2
Helomics Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Helomics Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Helomics Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Helomics Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Helomics Corp, Deals By Market, 2011 to YTD 2017 8
Helomics Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Precision Therapeutics Raises US$14 Million In Venture Financing 10
Healthcare Royalty Invests USD60 Million in Precision Therapeutics 11
Med BioGene Enters Into Licensing Agreement With Precision Therapeutics 12
Skyline Medical Forms Joint Venture with Helomics 14
Skyline Medical and Helomics Enter into Partnership 15
Helomics Partners with MDNA Life Sciences 16
Skyline Medical to Acquire 25% Stake in Helomics 17
Helomics Corp, Key Competitors 18
Helomics Corp, Key Employees 19

★海外企業調査レポート[Helomics Corp-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Anaren, Inc.:企業の戦略・SWOT・財務情報
    Anaren, Inc. - Strategy, SWOT and Corporate Finance Report Summary Anaren, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Myriad Genetics Inc (MYGN)-医療機器分野:企業M&A・提携分析
    Summary Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company’s product portfolio includes molecular diagnostic testing products that are designed to …
  • Factory Mutual Insurance Company:企業の戦略・SWOT・財務情報
    Factory Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Factory Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Johnson Matthey Plc (JMAT):電力:M&Aディール及び事業提携情報
    Summary Johnson Matthey Plc (Johnson Matthey) is a specialty chemicals and sustainable technologies provider. It offers catalysts, fine chemicals, specialty chemical products and related technologies for various chemical processes and applications. It also undertakes the marketing, distribution, fab …
  • El Gezirah Hotels & Tourism Co. S.A.E.:企業の戦略・SWOT・財務分析
    El Gezirah Hotels & Tourism Co. S.A.E. - Strategy, SWOT and Corporate Finance Report Summary El Gezirah Hotels & Tourism Co. S.A.E. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Seaboard Corp (SEB):企業の財務・戦略的SWOT分析
    Seaboard Corp (SEB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Power Machines:企業の戦略的SWOT分析
    Power Machines - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Apartment Investment and Management Co:企業の戦略・SWOT・財務情報
    Apartment Investment and Management Co - Strategy, SWOT and Corporate Finance Report Summary Apartment Investment and Management Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • NorgesGruppen ASA:企業の戦略的SWOT分析
    NorgesGruppen ASA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Perpetual Energy Inc (PMT):石油・ガス:M&Aディール及び事業提携情報
    Summary Perpetual Energy Inc (Perpetual Energy) is an upstream oil and gas company. It explores, develops and produces from shallow gas, liquids-rich gas, heavy oil, bitumen and other assets. The company produces light and medium crude oil, heavy oil natural gas and natural gas liquids. Perpetual En …
  • Donaldson Co Inc (DCI):企業の財務・戦略的SWOT分析
    Donaldson Co Inc (DCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Blue Dolphin Energy Company (BDCO):石油・ガス:M&Aディール及び事業提携情報
    Summary Blue Dolphin Energy Company (Blue Dolphin) is an oil and gas company that refines and markets petroleum products. The company own and operate pipeline assets and have leasehold interests in oil and gas properties. It also acquires, develops and explores oil and gas properties. Blue Dolphin o …
  • Gale Pacific Ltd (GAP):企業の財務・戦略的SWOT分析
    Gale Pacific Ltd (GAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Cobra Electronics Corporation:企業の戦略的SWOT分析
    Cobra Electronics Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Gigasolar Materials Corp (3691)-エネルギー分野:企業M&A・提携分析
    Summary Gigasolar Materials Corp (Giga Solar), formerly Gigastorage optoelectronic materials is a solar products manufacturing company that manufactures and markets solar conductive pastes. The company’s products include solar cell backside aluminium paste, solar cell front side silver paste, and so …
  • Glen Dimplex Group:企業の戦略的SWOT分析
    Glen Dimplex Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Purdue Pharma LP:製薬・医療:M&Aディール及び事業提携情報
    Summary Purdue Pharma LP (Purdue) is a privately held, US-based pharmaceutical company which develops pharmacologic therapies for the treatment and management of pain. The company undertakes the research, development, manufacture and marketing of prescription medicines and over-the-counter (OTC) med …
  • Fibrocell Science Inc (FCSC):製薬・医療:M&Aディール及び事業提携情報
    Summary Fibrocell Science Inc (Fibrocell Science) is an autologous cell and gene therapy company which discovers and develops therapies for diseases affecting the skin and connective tissue. The company’s product pipeline comprises FCX-007, a lead candidate for the treatment of recessive dystrophic …
  • Kellogg Co:企業のM&A・事業提携・投資動向
    Kellogg Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kellogg Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Assembly Biosciences Inc (ASMB):製薬・医療:M&Aディール及び事業提携情報
    Summary Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that develops, discovers, and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as microbiotic therapies for Clostridium diffic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆